Company Profile

Fine Foods & Pharmaceuticals N.T.M. S.p.A. specializes in the development and manufacturing of pharmaceutical, nutraceutical and cosmetic products for third parties.
Net sales break down by sector of activity between the food industry (60.5%), the pharmaceutical industry (27%) and the cosmetics industry (12.5%).
At the end of 2023, the group operated 3 production sites in Italy.
Export accounts for 50% of net sales.


Source: Cofisem - Last Update: 2024-09-16

Key Executives
Chief Executive Officer Pietro Oriani


Source: Cofisem - Last Update: 2024-09-16

Key Figures
Millenium 2023 2022 2021 2020 2019
Net sales 251,812 206,853 194,850 171,955,007 161,613,263
Income from ordinary activities 252,907 208,320 195,245 176,952,194 161,613,263
Operating income 1,066 -1,011 5,034 9,484,560 8,148,060
Cost of financial indebtedness net 3,926 2,029 685 476,378 476,691
Equity-accounted companies contribution to income
Net profit from discontinued activities
Net income -3,522 -9,501 -1,427 13,364,228 -2,790,264
Net income (Group share) -3,522 -9,501 -1,427 13,364,228 -2,790,264
Fiscal year end 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Length of fiscal year (month) 12 12 12 12 12
Currency & Unit EUR - thousands EUR - thousands EUR - thousands EUR - unit EUR - unit
Account Standards IFRS IFRS IFRS IFRS IFRS

Source: Cofisem - Last Update: 2024-09-16

Shareholder information
Group-owned stock 4.22 %
Eigenfin s.r.l. 52.7 %
Free float 43.08 %


Source: Cofisem - Last Update: 2024-09-16

Contact

Pietro Oriani
Phone number: 035 4821382
ir@finefoods.it


Source: Fine Foods & Pharmaceuticals N.T.M. S.p.A. - Last Update: 2024-09-16

Please contact MyQuestion.Italy@euronext.com for Company Profile support.

Quotazioni, Book, Dividendi, Documenti Societari, Corporate Governance, Internal Dealing di Fine Foods & Pharmaceuticals Ntm


The Exchange accepts no responsability for the content of the website you are now accessing or for any reliance placed by you or any person on the information contained on it.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.


You will be redirected in five seconds.